TMCnet News
New Study from StrategyR Highlights a $1.2 Billion Global Market for Next Generation Sequencing (NGS) Data Analysis by 2026SAN FRANCISCO, Jan. 4, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Next Generation Sequencing (NGS) Data Analysis - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.
FACTS AT A GLANCE Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry ABSTRACT- Global Next Generation Sequencing (NGS) Data Analysis Market to Reach US$1.2 Billion by the Year 2026 Next-generation sequencing (NGS) data analysis is widely used for investigating genomic and epigenomic patterns related to a wide range of biological processes. NGS data analysis encompasses primary, secondary and tertiary analysis steps, with some of these stages holding potential for automation through new sequencing solutions. Growth in the global market is set to be driven due to extensive uptake of the technology for analysis of RNA and DNA sequences. Cloud-based platforms are rapidly emerging as favorable solutions for performing computationally intensive activities during NGS data analysis makes it fast and simple for researchers to acquire computational resources for conducting large-scale data analysis of NGS. Recent technologial advancements in cloud computing and bioinformatics have led to the development of a wide array of cloud-based bioinformatics platforms and services for carrying out large-scale NGS data analysis, which is likely to propel significant market growth in the coming years. NGS methods are being extensively employed in genomic research, clinical diagnosis, and for oncology precision medicine, particularly for the diagnosis of breast and lung cancers. The rising prevalence of cancer cases across the globe is expected to boost growth in the global NGS data analysis market in the near future. Moreover, with tangible progress made towards personalized treatment of diseases, there is an increased demand for rapid and precise sequencing interpretation algorithms and tools that can help in expediting data analysis. Amid the COVID-19 crisis, the global market for Next Generation Sequencing (NGS) Data Analysis estimated at US$549.2 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2026, growing at a CAGR of 14.1% over the analysis period. Services, one of the segments analyzed in the report, is projected to grow at a 14.9% CAGR to reach US$814.1 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the NGS Commercial Software segment is readjusted to a revised 13% CAGR for the next 7-year period. This segment currently accounts for a 44% share of the global Next Generation Sequencing (NGS) Data Analysis market. Analytical software is expected to exhibit robust growth over the next few years, attributed to the increased awareness and growing demand for sequencing technologies. The vast quantities of data generated via NGS require management platforms and solutions, which is resulting in the rising demand for such algorithms and tools. Companies lacking the necessary infrastructure for data analysis, interpretation, and management are increasingly adopting cost-effective NGS data analysis services. The U.S. Market is Estimated at $238.7 Million in 2021, While China is Forecast to Reach $128.6 Million by 2026 The Next Generation Sequencing (NGS) Data Analysis market in the U.S. is estimated at US$238.7 Million in the year 2021. The country currently accounts for a 37.6% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$128.6 Million in the year 2026 trailing a CAGR of 15.1% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.8% and 13.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.1% CAGR while Rest of European market (as defined in the study) will reach US$101.9 Million by the end of the analysis period. The US is a major regional market for NGS data analysis, attributed to the presence of several established players, growing demand for personalized medicine, and launch of several large-scale genome sequencing projects in the region. Europe represents another major market. The region's dominance is attributed to the presence of several key global players, including Agilent Technologies, Illumina, and Thermo Fisher Scientific, coupled with the presence of a large number of regional players engaged in developing NGS data analysis software. There are also various European universities that are involved in conducting various NGS research projects, which is driving the adoption of NGS software tools in the region. More MarketGlass™ Platform Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android About Global Industry Analysts, Inc. & StrategyR™ CONTACTS: LINKS Connect With Us on LinkedIn Follow Us on Twitter Journalists & Media
SOURCE Global Industry Analysts, Inc. 
|
View original content to download multimedia: